BREAST CANCER;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CLINICAL TRIAL;
HIGH RISK PATIENT;
HUMAN;
LETTER;
MASTECTOMY;
ONCOLOGY;
PRIORITY JOURNAL;
RISK REDUCTION;
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer
Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27 (2009) 2466-2473
Sequencing of tamoxifen (TAM) and radiotherapy (RT) with breast conservation (BCT) in early stage breast cancer
abstr 39.
Pierce L.J., Hutchins L., Green S.J., et al. Sequencing of tamoxifen (TAM) and radiotherapy (RT) with breast conservation (BCT) in early stage breast cancer. Proc Am Soc Clin Oncol 22 (2003) abstr 39.
The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation therapy
abstr 40.
Christensen V.J., Harris E., Hwang W.-T., Fox K., and Solin L. The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation therapy. Proc Am Soc Clin Oncol 22 (2003) abstr 40.
Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer
Ishitobi M., Komoike Y., Motomura K., Koyama H., Nishiyama K., and Inaji H. Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer. Anticancer Res 29 (2009) 4791-4794
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial
10.1016/S1470-2045(10)70013-9 published online Feb 8.
Azria D., Belkacemi Y., Romieu G., et al. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol (2010) 10.1016/S1470-2045(10)70013-9 published online Feb 8.
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients
Azria D., Gourgou S., Sozzi W.J., et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 91 (2004) 1251-1260
